By selecting the Yes option, Leave Amgen.co.uk option, you understand that you are leaving the corporate page of Amgen UK and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Europe is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Europe. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Amgen is committed to working with medical professionals by providing them with the information they need to serve patients.
Amgen is dedicated to patient safety and continually monitors the safety and quality of our products. Side effects and product quality issues should be reported.
For the UK reporting forms and information can be found at the MHRA Yellow Card Website
Adverse events and product quality issues should also be reported to Amgen.
To report a potential adverse event or quality issue with an Amgen product, or for medical information enquiries,
please call +44 (0)1223 436441.
GBR-NP-0924-80023
January 2025